Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par pays : Switzerland
Femme et Homme Max 99 ans
Christoph Kniestedt, MD
MAJ Il y a 4 ans
GAT-DCT-Discordance Due to Corneal Properties
IOP is measured with two devices (Dynamic Contour Tonometry (DCT) and Goldmann applanation tonometry (GAT)).
Pays
Switzerland
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout
This study is designed to develop our understanding of the efficacy and safety of using lumiracoxib in the treatment of patients with acute gout. This is a multi-center, double-blind, rand...
Pays
Germany
,
Switzerland
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Martin Stocker, MD
MAJ Il y a 4 ans
Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis
Neonatal bacterial sepsis is a major cause of mortality and morbidity and early antibiotic therapy is crucial for treatment success. Objective: To evaluate the effect of Procalcitonin-gui...
Pays
Switzerland
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Stefan Breitenstein, MD
MAJ Il y a 4 ans
Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases
Hypothesis of the study: Neoadjuvant chemotherapy with Bevacizumab impairs postoperative outcome after resection of colorectal liver metastases.
Pays
France
,
Spain
,
Switzerland
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
ictrp
MAJ Il y a 4 ans
Positional therapy for obstructive sleep apnea: an objective measurement of efficacy and patients’ usage at home
Pays
Switzerland
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures
To evaluate long-term safety and efficacy of pregabalin in patients with partial seizures.
Pays
Australia
,
Austria
,
Belgium
,
Finland
,
France
,
Germany
,
Italy
,
Netherlands
,
South Africa
,
Spain
,
Sweden
,
Switzerland
,
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
André Mermoud, MD
MAJ Il y a 4 ans
Water Drinking Test During Intraocular Pressure Fluctuation (IOP) Monitoring
The purpose of this study is to investigate the investigational device capacity to detect an intraocular pressure increase (IOP)induced by water intake.
Pays
Switzerland
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Stephan Kraehenbuehl, Prof. Dr
MAJ Il y a 4 ans
Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)
The purpose of this study is to define the dose for a Phase II study and to investigate safety and tolerability of intravenous administration of recombinant soluble human Angiotensin Conve...
Pays
Switzerland
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials
The objective of this study is to collect retrospectively long term safety data in patients who have participated in the previous phase I-II trials conducted with the compound.
Pays
Belgium
,
France
,
Germany
,
Italy
,
Switzerland
,
United Kingdom
,
United States
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
To evaluate the safety, tolerability and efficacy of 3 doses of vernakalant (oral) (150 mg, 300 mg and 500 mg b.i.d.) administered for up to 90 days in subjects with sustained symptomatic ...
Pays
Germany
,
Hungary
,
Lithuania
,
Netherlands
,
New Zealand
,
Poland
,
Portugal
,
Romania
,
Russian Federation
,
Serbia
,
Singapore
,
Slovakia
,
South Africa
,
Spain
,
Sweden
,
Switzerland
,
Ukraine
,
Australia
,
Belgium
,
Bulgaria
,
Croatia
,
Czech Republic
,
Denmark
,
Estonia
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
8
9
10
11
12
13
14
15
16
17
Suivant